Cadenza Partners 2 ApS
CVR 46376528 · Private limited company (ApS) · Active · Medium risk
Cadenza Partners 2 ApS is a Private limited company (ApS), founded on , based in Gentofte. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. CEO: Jan Møller Mikkelsen.
Bankruptcy risk for Cadenza Partners 2 ApS
1.4 × the average (1.41%) · higher risk than 84% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 46376528
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (0 years)
- Address
- Soløsevej 24
2820 Gentofte - Municipality
- Gentofte
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 20k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 0 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jan Møller Mikkelsen | Current | |
| Owner (100%) | Jan Møller Mikkelsen | Current | |
| Founder | Jan Møller Mikkelsen | Current |
The CEOs' other companies
Jan Møller Mikkelsen – 15 other companies
- 7TM A/S Opløst
- ASCENDIS PHARMA A/S Active
- ASCENDIS PHARMA BONE DISEASES A/S Active
- ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S Active
- Ascendis Pharma Endocrinology Division A/S Active
- Ascendis Pharma Europe A/S Active
- Ascendis Pharma Growth Disorders A/S Active
- Ascendis Pharma Nordics A/S Opløst
- Ascendis Pharma Oncology Division A/S Active
- CADENZA PARTNERS ApS Active
- HYSCITE DISCOVERY A/S Compulsorily dissolved
- MAXYGEN ApS Opløst
- NEURONICON ApS Opløst
- NUEVOLUTION A/S Active
- PROFOUND INVEST A/S Opløst
Address history (0 moves)
| Soløsevej 24, 2820 Gentofte |
Other companies at the same address
- CADENZA PARTNERS ApS Active
- KOMPLEMENTARANPARTSSELSKABET SETA Compulsorily dissolved
- SEQUINEQ ApS Compulsorily dissolved
Similar companies in Gentofte
- HANDELS- & INDUSTRIAKTIESELSKABET AF 15. FEBRUAR 1980 Hellerup
- CCTV HOLDING A/S Gentofte
- ADYN ApS Hellerup
- DAN TECHNOLOGIES A/S Gentofte
- ORIMAGDOS ApS Charlottenlund
- DV 8 A/S Klampenborg
- Solbakkevej Invest ApS Gentofte
- KØBENHAVNS TAGDÆKNING HOLDING ApS Gentofte
- PERSPECTIVE HOLDING LTD. ApS Hellerup
- JÆGERSBORG HOTEL ApS Gentofte
- TURNKEY HOLDING APS Charlottenlund
- GERT MIKKELSEN ApS Hellerup
Questions and answers about Cadenza Partners 2 ApS
Has Cadenza Partners 2 ApS gone bankrupt?
No, Cadenza Partners 2 ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Cadenza Partners 2 ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of Cadenza Partners 2 ApS?
Jan Møller Mikkelsen is the CEO of Cadenza Partners 2 ApS.
When was Cadenza Partners 2 ApS founded?
Cadenza Partners 2 ApS was founded on 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.